Cost Effectiveness of Different Treatment Strategies in the Treatment of Patients with Moderate to Severe Rheumatoid Arthritis in China

Overview of attention for article published in PLOS ONE, October 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Sarilumab for moderate to severe rheumatoid arthritis: Committee papers

Cited by National Institute for Health and Care Excellence on 14 Sep 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Tofacitinib for moderate to severe rheumatoid arthritis: Committee papers

Cited by National Institute for Health and Care Excellence on 30 Aug 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.